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Abstract 
 
 
   This thesis introduces the use of a series of new experimental systems, 
and the corresponding signal processing techniques, to investigate the 
acoustic properties of ultrasound contrast agents, both in flowing and 
static conditions. Considered properties include backscatter, attenuation, 
resonance phenomena, nonlinear oscillation and destruction mechanisms 
as a function of the applied ultrasound parameters. These properties have 
been investigated by acoustic and granulometric measurements 
conducted on a last generation microbubble experimental contrast agent 
(BR14, Bracco Research SA, Geneva, Switzerland) for frequencies in 
the medical diagnostic range.  
   In the first part of this work, a new tissue-mimicking phantom was 
designed, manufactured and employed to evaluate microbubble behavior 
in very similar conditions to those encountered inside the human body. 
During these studies microbubbles were insonified by means of a 
common commercial echograph while flowing through the phantom, 
that had been inserted into an ad hoc assembled flow circuit, aimed to 
simulate human microcirculation conditions. In addition, in order to 
explore possible improvements in signal processing techniques, the 
echograph was connected to a prototypal platform for acquisition and 
independent processing of the raw unfiltered radiofrequency signals. 
   In the second part, whose focus was on the determination of 
microbubble intrinsic properties, microbubbles were studied in static 
conditions, employing single-element ultrasound probes driven by 
laboratory devices, offering higher flexibility in terms of generated 
signal parameters, and linked to high-performance data acquisition 
boards. 
   In particular, a new methodology has been developed to study 
microbubble destruction mechanisms and three main patterns have been 
identified in the microbubble acoustic behavior, also establishing the 
boundary conditions for the onset of the corresponding underlying 
phenomena. These findings could represent interesting bases for 
xv 
Abstract 
theoretical modeling of microbubble acoustic behavior from linear 
oscillation to complete shell disruption.    
   The outcome of each performed study has been also analyzed and 
interpreted to exploit possible implications for the improvement of 
current clinical techniques or for the potential development of new ones. 
   A global characterization of the acoustic behavior of the studied 
contrast agent is finally provided, together with many indications for its 
effective employment in further in vivo testing and clinical trials.  
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Introduction 
 
 
1.1 Medical ultrasound imaging and contrast enhancement 
 
   Ultrasonography is the most widely used clinical imaging technique in 
the world: it has been estimated that 100 million ultrasound scans of the 
heart, vascular system and abdominal organs are conducted worldwide 
each year [1]. Ultrasound imaging is so attractive for a number of 
reasons: it is versatile, not invasive, portable, easy to use, has low costs 
and produces real-time images. However, unlike the other major medical 
imaging modalities, such as X-ray radiology and magnetic resonance 
imaging, until a few years ago ultrasound techniques have suffered the 
lack of effective contrast agents. 
   A contrast agent, by definition, alters image contrast in a meaningful 
way that helps the diagnostician to distinguish between normal and 
abnormal conditions. Visualization of blood and blood flow within an 
organ is then essential for helping to differentiate normal tissues from 
injured ones [1]. 
   Medical ultrasound imaging is based on the echoes generated from 
inhomogeneities in the investigated tissues. These echoes are elaborated 
in the echographic scanner and used to compose images of the interior of 
the body. Ultrasound scatter from blood is much weaker than scatter 
from other tissues, typically 30 to 60 dB weaker [2], so the lumen of 
small vessels is not easily distinguishable from surrounding tissues. 
Hence the aim of introducing contrast agents is to increase the scatter of 
sound from blood. This is used to increase the information content in 
ultrasound images and to obtain diagnostic information not available 
without contrast agent (e.g. more accurate measurements of heart 
functional parameters, visualization of blood flow in small vessels, 
evaluation of tissue perfusion in various tissues and organs). 
   It has been widely showed [2,3] that very strong ultrasound scattering 
can be achieved by using extremely compressible particles, since they 
introduce a marked difference in acoustic impedance with respect to the 
surrounding blood. These particles have to pass successfully the 
1 
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pulmonary and coronary microcirculation and their longevity within the 
systemic circulation must be sufficient for an effective clinical 
examination to be performed. For these reasons, the most common and 
efficacious ultrasound contrast agents are in the form of gas-filled 
encapsulated microbubbles having diameters in the range 1-7 µm. 
Currently this is by far the most common approach to produce an 
ultrasound contrast agent [2], as confirmed by the fact that there are 
several microbubble contrast agents in clinical trials and a few are 
already commercially available [1]. 
   Contrast agents can provide real-time images of blood flowing through 
the heart chambers, vessels and capillary beds. Some agents are then 
slowed in the circulation of the liver and spleen or are taken up by 
phagocytic cells, specifically enhancing these organs [4]. Some other 
microbubbles can be designed to specifically target a receptor system, 
opening new exciting perspectives for molecular imaging and 
therapeutic applications of ultrasound contrast agents, potentially 
employable as carriers of drugs or genes. 
   Successful introduction of mentioned applications in clinical routine 
should dramatically increase the diagnostic performance of ultrasound 
imaging, while decreasing the time and cost for diagnosis together with 
the invasivity of the required examination. These considerations 
determined the widespread interest recently achieved by ultrasound 
contrast imaging, pushing research efforts in this field towards a deeper 
understanding of the dynamics of microbubble-ultrasound interactions, 
in order to effectively develop innovative microbubble detection 
strategies and to properly design new contrast agents particularly suited 
for each given application. 
   Next paragraphs provide a brief synthesis of the historical 
development of contrast echography, followed by an overview of current 
and future applications of ultrasound contrast agents. Specific aims of 
this study are then illustrated and, finally, the contents of the subsequent 
chapters are summarized. 
 
 
1.2 Historical development of contrast echography 
 
   Ultrasound contrast agents were pioneered in the late 1960s by 
Gramiak and Shah [5,6], who observed that strong short-lived echoes 
were generated in aorta and heart after agitated saline solutions 
containing free air bubbles had been injected into patients through an 
intra-aortic catheter. Shortly thereafter it was discovered that other fluids 
containing gas bubbles produced similar results. 
   Contrast effects discussed in those early experiences involved only 
free gas bubbles, with inherent shortcomings due to the bubble 
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generation method itself, such as indeterminate size, short life-time and 
inability to traverse the lung circulation. 
   However, this exciting new tool in echocardiography was explored by 
a large number of investigators in the period 1970-1980, as documented 
in the review by Meltzer and Roelandt [7]. All the research 
investigations performed in this period were aimed to determine in what 
manner this new method could enhance the diagnostic potentials of 
echocardiography. 
   Apart from the injection of the contrast material directly into the left 
side of the circulation by means of a catheter, left sided applications of 
contrast bubbles after intravenous injection were not possible in those 
years because of the blocking action of the lungs. 
   An important step forward in this area was the introduction of 
encapsulated microbubbles, whose first employments for remote sensing 
of local blood pressure [8] and for indicator dilution measurements [9] 
were reported in the late 1970s. Anyway, there was still the need for 
substantial improvements in the microbubble production processes 
before reasonably aiming to the introduction in clinical routine. 
   In the period 1980-1990 many clinical experiments were carried out in 
order to make contrast echocardiography an established technique. In the 
beginning of the 1980s researchers were forced to use home-made 
contrast agents: their studies were focused on determining myocardial 
perfusion and they were able to show that areas of normal and 
insufficient perfusion could be visualized [10]. 
   In 1984 Feinstein et al [11] reported the study of a sonication 
technique which produced small and stable microbubbles, whose 
transpulmonary effect was investigated by Ten Cate et al [12]. This was 
the first successfully reproducible method of producing microbubbles. In 
the same year a videodensitometric method for quantifying myocardial 
perfusion studies was also presented [13], stimulating an increasing 
interest for computer applications involving contrast ultrasound. 
   The first ultrasound contrast agents launched as commercial products 
in the early 1990s were Echovist (Schering AG, Germany) and Albunex 
(Molecular Biosystems Inc., USA). Echovist consisted of 
microcrystalline galactose particles that acted as a template providing 
nidation sites within which air bubbles formed when suspended in water 
[14], while Albunex consisted of air microbubbles inside heat-denatured 
human albumin shells [15]. These particles were, however, not stable 
enough to pass the pulmonary capillary bed and reach the left side of the 
heart when injected intravenously. Their survival within the systemic 
circulation could be measured in seconds, and thus provided limited 
utility. 
   Schering subsequently developed Levovist, which also consisted of 
microcrystalline galactose microparticles, but was complemented with 
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palmitic acid, which coated the microbubbles that formed after 
dissolution in water and vigorous agitation, providing increased stability 
[16,17]. 
   Molecular Biosystems, on the other hand, improved the intravascular 
stability of Albunex by replacing air with perfluoropropane. The new 
product, Optison, consisted of a ready-to-use suspension of 
microcapsules of heat-denatured human albumin filled with 
perfluoropropane [18-24]. This agent, which requires refrigerated 
storage, was introduced on the market in 1998. 
   Optison belongs to the so-called “second-generation ultrasound 
contrast agents” [25]. The most significant change in physical 
characteristics of microbubbles addressed by second generation agents 
was the gas content. In almost all agents, air was substituted by high-
molecular-weight perfluorocarbons, which are poorly soluble in water 
and blood, having longevity proportional to the length of their carbon 
chain [26,27]. 
   Another change took place in the composition of microbubble shell: 
semi-rigid shells of denatured albumin have progressively given way to 
lipid shells, that are more flexible and so require less acoustic energy to 
oscillate in such a manner to produce an effective ultrasound scattering. 
Differences in shell composition also resulted in different methods of 
producing microbubbles: while sonication is generally employed for the 
production of albumin shell microbubbles, mechanical or hand agitation 
is effective for producing microbubbles with lipid shells [25]. 
   The concentration of most microbubble contrast agents is in the range 
0.2-1.5 × 109 microbubbles/mL [28]. Research studies and clinical trials 
in humans indicated that doses of agent as low as 0.1 mL are sufficient 
for myocardial opacification, while even less is necessary for left 
ventricular opacification and delineation [29,30]. 
   The toxicity and safety of second generation microbubble contrast 
agents have been also widely investigated [29-32], showing that such 
agents produce no significant effects on cardiac or systemic 
hemodynamic function, myocardial blood flow, left ventricular wall 
thickening and pulmonary gas exchange. 
   Several second generation microbubble contrast agents are already 
available on the market since a few years [1], while further interesting 
experimental preparations are currently being evaluated, including, in 
particular, perfluorobutane-exposed sonicated dextrose albumin 
(PESDA) microbubbles [33], perfluorobutane microbubbles with 
phospholipidic shell, like BR14 (Bracco Research SA, Geneva, 
Switzerland) [34], and AI-700 (Acusphere, USA), consisting of 
perfluorocarbon-containing microbubbles enclosed in a biodegradable 
polymeric shell [35]. 
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1.3 Current and future applications of ultrasound contrast 
agents 
 
   Although the field of contrast ultrasound was born in the 1960s and 
was introduced into clinical application during the late 1980s and the 
1990s, it did not achieve widespread interest until very recent times. 
   Three critical breakthroughs, all achieved in the last few years, 
propelled the field into wider clinical practice and gave new energy to 
further research efforts: 1) with the introduction of second generation 
contrast agents, microbubble survival within systemic circulation was 
extended from seconds to minutes, thus making their use more attractive 
for many clinical purposes; 2) the advent of completely digital 
ultrasound equipments and the adoption of broadband transducers 
simplified the implementation of novel pulsing schemes and signal 
processing techniques; 3) the introduction of harmonic and pulse-
inversion imaging techniques allowed real-time suppression of tissue 
signals without affecting bubble signals, so dramatically increasing 
image contrast. 
   Microbubble contrast agents are designed to remain within the 
vascular space to image the blood pool. This characteristic is ideal for 
both contrast echocardiography and vascular imaging, particularly when 
combined with bubble-specific imaging modes such as harmonic 
imaging and pulse-inversion. Restriction of microbubbles to the vascular 
space, together with their capability of being destroyed by higher 
intensity ultrasound pulses, makes them very useful also for imaging 
solid organs such as liver and kidneys. 
   Applications of ultrasound contrast agents to cardiac, vascular and 
solid-organ imaging are shortly overviewed below, giving also 
indications on the potential further developments of contrast-enhanced 
echographic techniques in the various mentioned fields, including the 
new exciting perspectives of molecular imaging and therapeutic 
applications. 
 
1.3.1 Cardiac imaging 
   The development of effective ultrasound contrast agents consisting of 
injectable micrometer-sized gas bubbles that highlight the endocardial 
border has made contrast echocardiography a common clinical reality 
[36-39]. 
   Around 20% of conventional echographic examinations of the heart, in 
fact, does not provide images of adequate quality to allow visualization 
of inner border of the heart (endocardial border) for accurate diagnosis 
of ventricular dysfunction [1]. Thus, before the advent of ultrasound 
contrast agents, additional non-ultrasound testing procedures were 
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required, which were often more invasive, always more expensive, and 
sometimes presented also higher risk for the patient.  
   The use of contrast agents provided a clear delineation of the 
endocardial wall and improved definition of wall motion and thickening 
[40]. Enhanced endocardial border definition enabled a better evaluation 
of cardiac structure and function, which has lead to substantial 
improvements in diagnostic and prognostic accuracy and confidence. In 
particular, effective delineation of ventricular border helps to assess 
global heart function by accurately measuring the ejection fraction (the 
percentage of the blood in the left ventricle that is ejected during a heart 
beat). 
   New methods to achieve an accurate assessment of myocardial 
perfusion through microbubble contrast agents are currently in clinical 
trials, as well as innovative contrast ultrasound techniques to improve 
detection of coronary insufficiency. 
   Contrast-specific ultrasound imaging of the myocardium has in fact the 
potential to offer results equivalent to perfusion imaging with 
radiopharmaceuticals, both at rest and with exercise, with the advantage 
of providing real-time information on both heart function and perfusion 
[24], accompanied by the elimination of all the problems inherent the 
radioactive materials.  
 
1.3.2 Vascular imaging 
   The purposes of vascular imaging are [1]: 1) to verify that supply 
vessels are not occluded; 2) to assess the presence of arterial wall 
abnormalities such as atherosclerotic plaques and to evaluate their effect 
on flow; 3) to determine whether the direction of flow and velocity 
profile through the cardiac cycle are normal; 4) to acquire a visualization 
of the vascular tree within organs. 
   Standard Doppler imaging provides flow velocity data, but it is not 
reliable at demonstrating structural changes in vessels. Filling the vessel 
with the signal from contrast media has been already shown to be 
effective at detecting disease with X-ray angiography, X-ray-computed 
tomography and magnetic resonance imaging, and it is now extending 
also to ultrasound imaging. 
   Contrast agent employment in vascular imaging with ultrasound is 
important in addition for thrombus detection, since a blood clot typically 
assumes a similar appearance to blood, which allows the vessel to look 
normal when actually it may be totally occluded. Filling the vein with an 
ultrasound contrast medium allows for clear visualization of clots and 
even of the tiny channels that form as a clot begins to recanalize [41]. 
These channels are recognizable in consequence of the ability of 
ultrasound to detect single bubbles as they negotiate their way through 
the clot. This capability is particularly useful in the assessment of 
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abdominal and pelvic veins, which cannot be assessed by the application 
of an external compression over the vein. 
   When imaging the extracranial carotid arteries, standard echography 
cannot consistently depict the noncalcified atherosclerotic plaques. 
Filling the artery with an ultrasound contrast agent can accurately 
display the arterial inner wall, which helps to observe plaques in detail 
[42,43]. When tested in patients undergoing standard carotid X-ray 
angiography, contrast-enhanced ultrasonography was as accurate as X-
ray angiography in directly measuring the percentage of diameter 
reduction [43].    
   Further goals of contrast sonography now appear to be within reach in 
the field of vascular imaging. They include in particular providing more 
simple and more effective methods for detection and classification of 
plaques in the carotid arteries or abdominal or pelvic veins, based on 
innovative quantitative analysis of the corresponding contrast-enhanced 
echographic images. 
 
1.3.3 Solid-organ imaging 
   The ability to recognize perfused tissues and the pattern of perfusion is 
critical for the detection of diseased tissues. The use of an ultrasound 
contrast agent to fill all the tissue vascular spaces enables the clear 
depiction of regions not perfused, thus allowing the detection of vascular 
occlusion immediately after it occurs. Observing the pattern of perfusion 
as microbubbles fill the organ in real time also allows the detection of 
abnormal perfusion patterns, as is observed in tumors [44]. 
   Conventional echography is capable of detecting tumors within organs 
as they typically alter the appearance of normal tissue architecture. 
However, detecting small tumors (<2 cm) remains difficult, and even 
more difficult is to distinguish between benign and malignant tumors. 
Tumor detection rate for conventional echography of the liver, the most 
commonly involved solid organ, ranges from 40% to 70%, depending on 
the operator skill [1]. 
   By observing the filling pattern and the arterial tree within an organ in 
real time, contrast-specific ultrasound imaging can not only enable the 
detection of abnormal regions, but also improve the ability to 
characterize diseases [45].  
   The introduction of contrast echography has already allowed the 
quantification of tumor microcirculation and the assessment of 
angiogenesis consequent to tumor growth [46]. Significant improvement 
in disease detection and characterization has been achieved in recent 
years both in animal models and in humans [45,47,48]. Clinical 
investigations of prostate vascularity have also indicated that contrast 
agents may improve the echographic detection of prostate cancer [47] 
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and that renal cortical blood flow and ischemia can be assessed as well 
[49]. 
   Furthermore, microbubbles have demonstrated to be useful for 
imaging the liver after they have been taken up by the reticulo-endotelial 
system  and to aid the visualization of liver lesions, including carcinoma 
and small metastases [50,51]. 
   The full clinical potential of ultrasound contrast agents for solid-organ 
imaging is still far from exploited and its development appears 
extremely promising. Currently the main research goals in this field are 
optimal quantification of regional ischemia or infarction, enhancement 
of the accuracy of cancer detection, more accurate characterization and 
staging of tumors in organs such as liver, breast and prostate. Research is 
also underway to look at brain perfusion [52]. 
 
1.3.4 Molecular imaging and therapeutic applications 
   The increased diagnostic accuracy and reliability gained by combining 
second generation ultrasound contrast agents with improvements in the 
software instruments, together with the low cost and portability of this 
imaging technique relative to most other modern diagnostic modalities, 
are likely to further expand the range of ultrasound imaging applications. 
Further medical advances involving microbubbles, in particular, are 
emerging in fields such as specific tissue targeting and drug or gene 
delivery. 
   Microbubbles can be outfitted with a targeting device and used to seek 
and mark specific targets, which then become visible during ultrasound 
imaging. Such detection of the specific molecular signature of a given 
pathology is referred to as “molecular imaging” [53]. Privileged target 
tissues include thrombi, atheroma plaques, areas of inflammation and 
tumors [54-56]. 
   Microbubbles subjected to ultrasound have also a potential as 
therapeutic tools. For example, in vivo arterial thrombolysis has been 
achieved in rabbits without a thrombolytic drug, but simply using 
microbubbles and externally applying ultrasound energy [57,58].   
   Finally, the combination of bubble targeting and ultrasound-triggered 
bubble disruption in the targeted tissue offers further opportunities. A 
drug substance can in fact be incorporated into the shell of a bubble or 
attached to its surface. Bubble/drug circulation and distribution can then 
be  monitored by ultrasound imaging. Therefore, ultrasound-mediated 
bubble disruption and local release of the active substances can be 
triggered and focused when the microspheres reach the intended target. 
This strategy could help to protect surrounding normal tissue from toxic 
drugs. 
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1.4 Aims of this study 
 
   The key to further developing the above mentioned clinical diagnostic 
procedures lies in a deeper understanding of the influence of ultrasound 
transmission parameters on contrast microbubble behavior. 
   Assessing the efficacy of ultrasound contrast agents on the basis of 
their physical characteristics is a complex issue. The characterization of 
the contrast media behavior, in fact, requires in vitro attenuation and 
scattering experiments to be performed on a wide range of parameter 
settings and so, during past years, microbubble dynamics have been 
widely investigated [59-65]. In particular, it is known from literature 
[66] that the dependency of bubble volume pulsation on the incident 
pressure amplitude can be divided into three regimes: linear oscillation 
at low pressure, nonlinear oscillation with harmonic emission at 
intermediate pressure and bubble rupture associated with a strong 
transient backscatter enhancement at higher pressure. 
   This thesis introduces a series of new experimental systems aimed to 
provide a global characterization of the acoustical behaviour of a last 
generation experimental contrast agent (BR14, Bracco Research SA, 
Geneva, Switzerland), both in flowing and static conditions. Main 
microbubble properties have been then considered and are related to 
backscatter, attenuation, resonance phenomena, nonlinear oscillation and 
destruction mechanisms as a function of the applied ultrasound 
parameters.  
   Experimental results can be also exploited in terms of possible 
implications for effective clinical employment of the studied agent and 
potential improvement of current microbubble detection strategies. 
   In addition, some previous studies [66-76] specifically investigated 
nonlinear properties of contrast microbubbles, aiming to improve 
existing contrast-assisted imaging modalities and to develop new ones. 
Our effort has been addressed to the characterization of a new 
experimental contrast agent, that was not previously covered by any of 
those studies. 
   Moreover, improved knowledge of microbubble destruction 
phenomena could allow to choose the contrast agent better suited for a 
given application. Just to cite two important cases, we could refer to 
reperfusion imaging [77-79], made possible by the knowledge of 
acoustic pressure thresholds for microbubble destruction, and therapeutic 
applications [80-83], which require the use of thick-shelled 
microbubbles, robust enough to carry drug or gene and then to be 
destroyed at higher acoustic pressures. 
   A further goal of this thesis was, then, the implementation of new 
techniques to improve the theoretical and experimental knowledge of 
microbubble behavior by means of attenuation measurements, with the 
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specific aim of determining pressure thresholds for the onset of 
nonlinearities and different destruction mechanisms for the investigated 
microbubbles. In order to do this, results of detailed granulometric 
analyses performed on microbubble solutions have been exploited and 
closely correlated with acoustic measurement outcome, giving new 
perspectives in the interpretation of microbubble population behavior. 
 
 
1.5 Thesis organization 
 
   This thesis consists of twelve chapters and it is conceptually divided 
into four parts. After this introductory chapter, the first part, Ultrasound 
imaging and contrast agents, summarizes basic principles of 
echographic imaging and microbubble contrast agents and comprises 
chapters 2 and 3: 
 
• Chapter 2 briefly reviews physical principles related to 
generation and propagation of ultrasound signals. Fundamental 
steps of echographic image reconstruction are also explained. 
 
• Chapter 3 is focused on ultrasound-microbubble interaction, 
giving details about involved physical phenomena, main 
available theoretical models and contrast imaging methods that 
are currently used or under investigation. 
 
   After the illustration of the theoretical background underlying the 
experimental studies reported in this thesis, the second part, entitled 
Phantom design and production and comprising chapters 4-6, describes 
the procedures adopted for manufacturing the tissue-mimicking 
“phantom” (which has to be intended as a simplified vascular model of a 
target human organ) and the assembly of an appropriate flow circuit:  
 
• Chapter 4 illustrates the synthesis and characterization processes 
of a new tissue-mimicking hydrogel, able to accurately simulate 
linear and nonlinear acoustic properties of liver tissue, that had 
been chosen as the target tissue for this study. 
 
• Chapter 5 shows the experimental procedure adopted to select a 
sound-absorbent material to cover the phantom bottom, in order 
to minimize artefacts due to environmental boundary conditions. 
 
• Chapter 6 depicts the progressive steps of phantom fabrication 
and testing, until the final phantom production. Details of the 
assembled flow circuit are also provided. 
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   Then, the third part, Microbubbles in flowing conditions, comprising 
chapters 7-8 and aimed to evaluate microbubble behavior in very similar 
conditions to those encountered inside the human body, describes the 
main studies conducted on flowing microbubbles employing the 
experimental set-up introduced in previous chapters: 
 
• Chapter 7 discusses the effect of incident ultrasound amplitude 
on microbubble backscattered signal. 
 
• Chapter 8 addresses the effect of contrast agent concentration on 
the amplitude of ultrasound signals backscattered by 
microbubbles. Some considerations are also made on variable 
effectiveness of different ways of indicating contrast agent 
concentration itself. 
 
   In the fourth part, entitled Microbubbles in static conditions and 
comprising chapters 9-11, focus is moved on the determination of 
microbubble intrinsic properties through the employment of different 
experimental set-ups and innovative methodologies of data analysis: 
 
• Chapter 9 describes the employment of a new hydrogel-
containing set-up, just designed to estimate optimal acoustic 
pressures for effective microbubble imaging in different 
echographic modalities. 
 
• Chapter 10 introduces the last experimental set-up developed 
within this thesis: a new system for acoustic attenuation 
measurements in “through-transmission” mode. Its application in 
estimating microbubble nonlinear oscillation threshold is also 
shown. 
 
• Chapter 11 presents the assessment of microbubble destruction 
mechanisms, which is achieved through a new methodology 
based on the combination of acoustic and granulometric 
measurements. Main obtained results are grouped into three main 
patterns, representing a proposed model of BR14 microbubble 
acoustical behavior. 
 
   Finally, in chapter 12, the most important conclusions of this work are 
summarized and some speculations are given on the most promising 
future developments of this research topic.  
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